Visudyne Interactions
There are 256 drugs known to interact with Visudyne (verteporfin), along with 2 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 1 is major, 242 are moderate, and 13 are minor.
- View all 256 medications that may interact with Visudyne
- View Visudyne alcohol/food interactions (1)
- View Visudyne disease interactions (2)
Most frequently checked interactions
View interaction reports for Visudyne (verteporfin) and the medicines listed below.
- acetaminophen
- acetazolamide
- acetylcysteine
- acrivastine
- Actemra (tocilizumab)
- acyclovir
- acyclovir topical
- Adalat (nifedipine)
- adenovirus vaccine
- Adriamycin RDF (doxorubicin)
- Afinitor Disperz (everolimus)
- Alcaine (proparacaine ophthalmic)
- Alimta (pemetrexed)
- Allegra (fexofenadine)
- Alocril (nedocromil ophthalmic)
- Amevive (alefacept)
- Amjevita (adalimumab)
- Avastin (bevacizumab)
- boric acid ophthalmic
- cefuroxime
- Celestone (betamethasone)
- ciprofloxacin
- Eylea (aflibercept ophthalmic)
- ketorolac ophthalmic
- levofloxacin
- Lucentis (ranibizumab ophthalmic)
- Luxturna (voretigene neparvovec ophthalmic)
- Macugen (pegaptanib ophthalmic)
- Oncovin (vincristine)
- prednisone
Visudyne alcohol/food interactions
There is 1 alcohol/food interaction with Visudyne (verteporfin).
Visudyne disease interactions
There are 2 disease interactions with Visudyne (verteporfin) which include:
Report options
QR code containing a link to this page
More about Visudyne (verteporfin)
- Visudyne consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.